Sarepta Therapeutics Stock Market Value

SRPT Stock  USD 130.23  1.98  1.54%   
Sarepta Therapeutics' market value is the price at which a share of Sarepta Therapeutics trades on a public exchange. It measures the collective expectations of Sarepta Therapeutics investors about its performance. Sarepta Therapeutics is selling for under 130.23 as of the 28th of March 2024; that is 1.54 percent increase since the beginning of the trading day. The stock's last reported lowest price was 127.36.
With this module, you can estimate the performance of a buy and hold strategy of Sarepta Therapeutics and determine expected loss or profit from investing in Sarepta Therapeutics over a given investment horizon. Check out Sarepta Therapeutics Correlation, Sarepta Therapeutics Volatility and Sarepta Therapeutics Alpha and Beta module to complement your research on Sarepta Therapeutics.
For more information on how to buy Sarepta Stock please use our How to Invest in Sarepta Therapeutics guide.
Symbol

Sarepta Therapeutics Price To Book Ratio

Is Sarepta Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sarepta Therapeutics. If investors know Sarepta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sarepta Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.80)
Revenue Per Share
13.456
Quarterly Revenue Growth
0.535
Return On Assets
(0.05)
Return On Equity
(0.86)
The market value of Sarepta Therapeutics is measured differently than its book value, which is the value of Sarepta that is recorded on the company's balance sheet. Investors also form their own opinion of Sarepta Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sarepta Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sarepta Therapeutics' market value can be influenced by many factors that don't directly affect Sarepta Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sarepta Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sarepta Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sarepta Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sarepta Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sarepta Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sarepta Therapeutics.
0.00
02/27/2024
No Change 0.00  0.0 
In 30 days
03/28/2024
0.00
If you would invest  0.00  in Sarepta Therapeutics on February 27, 2024 and sell it all today you would earn a total of 0.00 from holding Sarepta Therapeutics or generate 0.0% return on investment in Sarepta Therapeutics over 30 days. Sarepta Therapeutics is related to or competes with Agilent Technologies, Equillium, Kineta, and Mediwound. Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RN... More

Sarepta Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sarepta Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sarepta Therapeutics upside and downside potential and time the market with a certain degree of confidence.

Sarepta Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Sarepta Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sarepta Therapeutics' standard deviation. In reality, there are many statistical measures that can use Sarepta Therapeutics historical prices to predict the future Sarepta Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sarepta Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
127.35130.43133.51
Details
Intrinsic
Valuation
LowRealHigh
117.21159.11162.19
Details
Naive
Forecast
LowNextHigh
137.01140.09143.17
Details
23 Analysts
Consensus
LowTargetHigh
164.36180.61200.48
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sarepta Therapeutics. Your research has to be compared to or analyzed against Sarepta Therapeutics' peers to derive any actionable benefits. When done correctly, Sarepta Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sarepta Therapeutics.

Sarepta Therapeutics Backtested Returns

Sarepta Therapeutics appears to be very steady, given 3 months investment horizon. Sarepta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.17, which indicates the firm had a 0.17% return per unit of risk over the last 3 months. By inspecting Sarepta Therapeutics' technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please review Sarepta Therapeutics' Risk Adjusted Performance of 0.1174, coefficient of variation of 508.39, and Semi Deviation of 1.63 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sarepta Therapeutics holds a performance score of 13. The entity has a beta of 0.0283, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sarepta Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Sarepta Therapeutics is expected to be smaller as well. Please check Sarepta Therapeutics' downside variance, as well as the relationship between the daily balance of power and relative strength index , to make a quick decision on whether Sarepta Therapeutics' existing price patterns will revert.

Auto-correlation

    
  -0.69  

Very good reverse predictability

Sarepta Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Sarepta Therapeutics time series from 27th of February 2024 to 13th of March 2024 and 13th of March 2024 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sarepta Therapeutics price movement. The serial correlation of -0.69 indicates that around 69.0% of current Sarepta Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient-0.69
Spearman Rank Test-0.83
Residual Average0.0
Price Variance6.05

Sarepta Therapeutics lagged returns against current returns

Autocorrelation, which is Sarepta Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sarepta Therapeutics' stock expected returns. We can calculate the autocorrelation of Sarepta Therapeutics returns to help us make a trade decision. For example, suppose you find that Sarepta Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Sarepta Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sarepta Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sarepta Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sarepta Therapeutics stock over time.
   Current vs Lagged Prices   
       Timeline  

Sarepta Therapeutics Lagged Returns

When evaluating Sarepta Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sarepta Therapeutics stock have on its future price. Sarepta Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sarepta Therapeutics autocorrelation shows the relationship between Sarepta Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Sarepta Therapeutics.
   Regressed Prices   
       Timeline  

Sarepta Therapeutics Investors Sentiment

The influence of Sarepta Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Sarepta. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Sarepta Therapeutics' public news can be used to forecast risks associated with an investment in Sarepta. The trend in average sentiment can be used to explain how an investor holding Sarepta can time the market purely based on public headlines and social activities around Sarepta Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sarepta Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sarepta Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Sarepta Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Sarepta Therapeutics.

Sarepta Therapeutics Implied Volatility

    
  76.34  
Sarepta Therapeutics' implied volatility exposes the market's sentiment of Sarepta Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sarepta Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sarepta Therapeutics stock will not fluctuate a lot when Sarepta Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sarepta Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sarepta Therapeutics' short interest history, or implied volatility extrapolated from Sarepta Therapeutics options trading.

Currently Active Assets on Macroaxis

When determining whether Sarepta Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Sarepta Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Sarepta Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Sarepta Therapeutics Stock:
Check out Sarepta Therapeutics Correlation, Sarepta Therapeutics Volatility and Sarepta Therapeutics Alpha and Beta module to complement your research on Sarepta Therapeutics.
For more information on how to buy Sarepta Stock please use our How to Invest in Sarepta Therapeutics guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Sarepta Stock analysis

When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sarepta Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sarepta Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...